Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Apr 04, 2024 11:11pm
80 Views
Post# 35971886

RE:New Aveeno and Neutrogena research

RE:New Aveeno and Neutrogena research

Research on Hydrocolloid Patches as a Fast-Acting Treatment for Acne. The Science Behind a Viral Trend: Demonstrating Tolerance and Efficacy of Hydrocolloid Patch for Facial Acne

  • Kosmoski G, et al. People with acne often become frustrated and noncompliant when using traditional over-the-counter and prescription acne treatments, as these solutions can take a long time to become effective. Consumers looking for an overnight response have been gravitating toward over-the-counter hydrocolloid patches, but HCPs have called for data confirming their effectiveness. Researchers responded by conducting a randomized trial of the Neutrogena® Stubborn Acne Hydrocolloid Patch in people with mild to moderate acne.
  • The research team found that those who used the patches perceived a noticeable reduction in the size, texture, and redness of both closed and popped pimples within a day compared with those who did not use the patches. They concluded that these non-medicated patches are an effective option for overnight improvements to acne.


Research on Colloidal Oats as a Topical Ingredient to Prevent and Treat Dry, Itchy Skin Infant Skin Microbiome is Associated with Decreased Risk of Atopic Dermatitis and Affected by Early Use of an Emollient

  • Insel RA, et al. The children of parents with allergic disease may have an increased likelihood of developing atopic dermatitis, also known as eczema. To explore a potential prevention strategy, investigators recommended the twice daily application of an oat- and glycerin-containing emollient to children in this population from birth through the age of 8 weeks. Compared with a control group, DNA sequencing of skin microbiome samples collected from the cheeks and elbows showed that children treated with the emollient from birth to 2 months enjoyed lasting effects, with greater abundance of skin-health associated microflora and a lower risk of developing eczema at ages 6 and 12 months.

2-Week Application of Topical Colloidal Oatmeal Gel Cream Supports the Growth of Skin Commensal Staphylococcus Epidermidis in Subjects with Mild-to-Moderate Atopic Dermatitis

  • Comito N, et al. A 2% colloidal oatmeal gel cream has been found to ease eczema, and researchers sought to confirm exactly how the treatment reverses this chronic dryness. In adults with mild to moderate eczema who used the cream on dry skin twice daily for two weeks, microbiome testing showed an increase in the presence of Staphylococcus epidermidis, an organism associated with healthy skin.

Adherence to Continuous Use of an Oat Containing Moisturizer Increases Well-Being of Patients with Psoriasis Undergoing Immunobiological Therapy

  • Renno I, et al. Psoriasis can impact patients’ quality of life due to itchy skin lesions and self-consciousness about appearance. But in this large study of patients receiving an immunobiological treatment for the chronic condition, most reported that concomitant self-care with an oat-containing moisturizer contributed to their well-being and improved their complexion. These results satisfied HCP requests for evidence demonstrating the efficacy of such a moisturizer in this population of patients.

An Oat-Containing Cream Designed to Boost Loricrin, Claudin 1 and Improve Skin Barrier: Observation from In Vitro and Clinical Studies

  • Wang Q, et al. To confirm preclinical findings that an oat-containing cream improved skin barrier function, the authors tested the formula in women with dry skin. Four weeks after baseline, they found that participants had significantly higher levels of the proteins that regulate overall skin condition, skin moisture, and transdermal water loss. Furthermore, after study treatment was stopped, skin improvements were maintained for at least three days.

Benefits of a Colloidal Oatmeal Cream with Biomimetic Lipid Combination and Beta Glucan Active in Atopic Dermatitis in Brazilian Multi-Ethnic Patients: Instrumental, Clinical, Microbiome, Images, and Patient-Perception

  • Renno I, et al. This study shows that an oat-based “recovering cream” was consistently ranked effective and well tolerated in a diverse population of patients with eczema according to a wide range of investigative instruments, supporting the importance of moisturization. Improvements associated with use of the cream included more thorough skin hydration, a reduction in the presence of the unhealthy bacteria Staphylococcus Aureus, less discomfort, and a better quality of life. Those outcomes were confirmed via Scoring Atopic Dermatitis (SCORAD), the Patient Oriented Eczema Measure (POEM), instrumental measurements, images, skin microbiome analysis, and patient self-assessment.

A Cooling Gel Cream with Oat Provides Improvement in Quality of Life for Everyday Lifestyle Impact, and Itch Frequency & Bother, in Atopic Dermatitis Patients

  • Draelos ZD, et al. With prior research supporting the clinical benefits of a 2% oat-containing cooling gel cream for people with eczema, investigators wanted to learn more about the formula’s contributions to quality of life. After using the cream for two weeks, more patients classified their itchiness as infrequent and minimally bothersome than at the study’s start. Participants also said they felt better prepared to manage their eczema and that they appreciated the cooling relief provided by the gel.
<< Previous
Bullboard Posts
Next >>